Related Experiment Video
Updated: Aug 7, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
miR-382 Contributes to Renal Tubulointerstitial Fibrosis by Downregulating HSPD1
Yi Fang1,2,3, Ting Xie1, Ning Xue1
1Department of Nephrology, Zhongshan Hospital, Fudan University, Shanghai, China.
Abstract:
Redox imbalance plays an important role in the pathogenesis of CKD progression. Previously, we demonstrated that microRNA-382 (miR-382) contributed to TGF-β1-induced loss of epithelial polarity in human kidney epithelial cells, but its role in the development of renal tubulointerstitial fibrosis remains unknown. In this study, we found that with 7 days of unilateral ureteral obstruction (UUO) in mice, the abundance of miR-382 in the obstructed kidney was significantly increased. Meanwhile, the protein expression of heat shock protein 60 (HSPD1), a predicted target of miR-382, was reduced after 7 days of UUO. Expression of 3-nitrotyrosine (3-NT) was upregulated, but expression of thioredoxin (Trx) was downregulated. Anti-miR-382 treatment suppressed the upregulation of miR-382, attenuated renal interstitial fibrosis in the obstructed kidney, and reversed the downregulation of HSPD1/Trx and upregulation of 3-NT after UUO. Furthermore, in vitro study revealed that overexpression of HSPD1 significantly restored Trx expression and reversed TGF-β1-induced loss of E-cadherin, while in vivo study found that direct siRNA-mediated suppression of HSPD1 in the UUO kidney promoted oxidative stress despite miR-382 blockade. Our clinical data showed that upregulation of miR-382/3-NT and downregulation of HSPD1/Trx were also observed in IgA nephropathy patients with renal interstitial fibrosis. These data supported a novel mechanism in which miR-382 targets HSPD1 and contributes to the redox imbalance in the development of renal fibrosis.
Insights
MicroRNA-382 (miR-382) exacerbates kidney fibrosis by targeting heat shock protein 60 (HSPD1), leading to redox imbalance. Inhibiting miR-382 may offer a therapeutic strategy for chronic kidney disease (CKD).
Area of Science:
- Nephrology
- Molecular Biology
- Oxidative Stress Research
Background:
- Redox imbalance is a key factor in chronic kidney disease (CKD) progression.
- MicroRNA-382 (miR-382) is implicated in epithelial polarity loss but its role in renal fibrosis is unclear.
Purpose of the Study:
- To investigate the role of miR-382 in the development of renal tubulointerstitial fibrosis.
- To elucidate the underlying molecular mechanisms involving redox imbalance and potential targets.
Main Methods:
- Unilateral ureteral obstruction (UUO) model in mice to induce kidney fibrosis.
- In vitro studies using kidney epithelial cells and TGF-β1 stimulation.
- Analysis of miR-382, heat shock protein 60 (HSPD1), 3-nitrotyrosine (3-NT), and thioredoxin (Trx) expression.
- Treatment with anti-miR-382 and siRNA targeting HSPD1.
Main Results:
- miR-382 and 3-NT were upregulated, while HSPD1 and Trx were downregulated in UUO kidneys and in patients with IgA nephropathy and fibrosis.
- Anti-miR-382 treatment attenuated fibrosis, reversed molecular changes, and reduced oxidative stress.
- HSPD1 overexpression restored Trx and E-cadherin, while HSPD1 suppression promoted oxidative stress.
Conclusions:
- miR-382 targets HSPD1, contributing to redox imbalance and promoting renal tubulointerstitial fibrosis.
- Targeting miR-382 presents a potential therapeutic approach for kidney fibrosis.
- The miR-382/HSPD1 axis is a novel mechanism in CKD pathogenesis.

